Active	Status	Sponsor type	Region	Phase	Filter
17 Active 0 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Her, Sung-Ho
NCT05807841: Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)	Recruiting	N/A	3000	RoW	percutaneous coronary intervention	Asan Medical Center, Boston Scientific Corporation	Coronary Artery Disease	06/28	06/29
IRIS FFR, NCT01366404: Study of the Natural History of FFR Guided Percutaneous Coronary Intervention	Recruiting	N/A	20000	RoW		Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices	Coronary Artery Disease	04/37	04/37
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD	Recruiting	N/A	2400	RoW	Percutaneous Coronary Intervention	Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd	Coronary Disease	12/26	07/30
STRIKE-CTO, NCT03667196: Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions	Recruiting	N/A	4000	RoW	antegrade and retrograde approach	Seung-Whan Lee, M.D., Ph.D., Abbott Medical Devices, Biotronik SE & Co. KG, Medtronic, Dio Medical	Chronic Total Occlusion of Coronary Artery	12/27	12/27
Park, Han-Bit
NCT05807841: Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)	Recruiting	N/A	3000	RoW	percutaneous coronary intervention	Asan Medical Center, Boston Scientific Corporation	Coronary Artery Disease	06/28	06/29
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus	Recruiting	N/A	4000	RoW	high-intensity statin arm, low-intensity statin plus ezetimibe	Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation	Pre Diabetes, ASCVD	12/27	12/27
STRIKE-CTO, NCT03667196: Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions	Recruiting	N/A	4000	RoW	antegrade and retrograde approach	Seung-Whan Lee, M.D., Ph.D., Abbott Medical Devices, Biotronik SE & Co. KG, Medtronic, Dio Medical	Chronic Total Occlusion of Coronary Artery	12/27	12/27